Cloud-native Manufacturing Execution System (MES) delivering real-time production control, quality management, and compliance capabilities for pharmaceutical manufacturing operations.
Plex MES is a cloud-native Manufacturing Execution System acquired by Rockwell Automation in 2021 for $2.22 billion. The platform provides comprehensive manufacturing operations management including production control, quality management, inventory tracking, equipment maintenance, and compliance capabilities designed for regulated industries.
As part of the Rockwell Automation ecosystem, Plex integrates with FactoryTalk software, Allen-Bradley control systems, and other industrial automation equipment. The platform delivers real-time visibility into production operations with electronic batch records, material genealogy, and comprehensive audit trails supporting GxP compliance requirements.
Plex MES runs as cloud-native SaaS with no on-premise infrastructure, providing security, scalability, and regular platform updates. The system supports FDA 21 CFR Part 11 compliance with electronic signatures, tamper-proof audit trails, and data integrity features aligned with ALCOA+ principles.
The platform targets mid-to-large pharmaceutical and life sciences manufacturers with complex production operations, regulatory compliance requirements, and real-time operational visibility needs across multiple facilities. Plex MES serves 700+ manufacturing companies globally, including pharmaceutical, biotechnology, medical device, and other regulated industries.
Plex MES is delivered exclusively as a cloud-native SaaS solution hosted on enterprise-grade infrastructure with multi-tenant architecture. The platform is accessible via web browser with no local installation required, supporting both desktop and mobile access for shop floor operations.
The system provides comprehensive REST APIs for integration with ERP systems (SAP, Oracle, Microsoft Dynamics), quality systems, laboratory systems, and other enterprise applications. Native integration with Rockwell Automation's FactoryTalk ecosystem enables connectivity to Allen-Bradley PLCs, HMIs, and industrial control systems. Data connectivity supports real-time machine integration, IoT sensors, and automated data collection from production equipment.
Security architecture includes SOC 2 Type II certification, data encryption in transit and at rest, role-based access control, and comprehensive audit logging. The platform supports single sign-on (SSO) via SAML 2.0 and Active Directory integration. Regular platform updates are delivered through the cloud infrastructure with minimal customer impact and support for validation in regulated environments.
Public pricing is undisclosed. Plex MES uses a subscription-based pricing model with annual or multi-year licensing agreements, typically structured on number of users, production volume, number of facilities, and specific modules deployed.
Typical deal sizes for pharmaceutical manufacturing implementations range from $200,000–$800,000+ annually depending on scope and scale. Implementation services are quoted separately based on project requirements. The subscription includes platform access, regular updates, cloud infrastructure, and standard support. Premium support tiers and additional professional services are available.
Prospects can request product demonstrations and proof-of-concept deployments. Free trials are not publicly advertised. Pricing and detailed proposals are available through direct contact with Rockwell Automation sales representatives or authorized system integrators.
Plex MES implementation typically ranges from 3–9 months depending on facility size, complexity, and scope of deployment. Rockwell Automation provides comprehensive implementation services including project management, system configuration, data migration, integration development, user training, and go-live support.
The platform's cloud-native architecture eliminates infrastructure setup time and reduces technical implementation complexity. Data migration support includes tools for importing master data, historical records, and legacy system integration. The platform provides validation documentation packages including installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) templates for pharmaceutical implementations.
Rockwell Automation offers ongoing support through customer success programs, technical support services, and a global network of system integrators experienced in pharmaceutical manufacturing. The platform receives regular updates delivered through the cloud infrastructure with change control processes designed to minimize validation impact in regulated environments.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Users appreciate Plex MES for its cloud-native architecture eliminating on-premise infrastructure requirements and regular platform updates. The integration with Rockwell Automation's broader ecosystem is valued by facilities already using Allen-Bradley equipment and FactoryTalk software. Users note capabilities in production tracking, quality management, and real-time visibility. Mobile accessibility and the user interface are frequently highlighted. Customer support from Rockwell Automation receives positive feedback, particularly for pharmaceutical implementations requiring validation assistance.
Implementation complexity and timeline can be significant for comprehensive deployments. Some users report the system requires substantial configuration and customization to meet specific pharmaceutical requirements. The pricing model is considered expensive. Users transitioning from other MES platforms note a learning curve for administrators and end users. Integration with non-Rockwell automation equipment may require additional effort. Some pharmaceutical users report challenges with the pace of cloud platform updates in highly validated environments.
Share your experience with Plex MES anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section